Patients demographics and clinicobiologic characteristics
| . | Overall . |
|---|---|
| No. | 500 |
| Median age (range) | 49 (18-60,9) |
| Sex, n (%) | |
| Male | 260 (52) |
| Female | 240 (48) |
| Median WBCc (range) | 14 × 109/L (0.16-352) |
| Cytogenetics: FR, n (%) | 47 (11) |
| Cytogenetics: IR, n (%) | 315 (73) |
| Cytogenetics: PR, n (%) | 67 (16) |
| RUNX1/RUNX1T1, n (%) | 27 (5) |
| RUNX1/RUNX1T1/c-KITmut, n (%) | 12/27 (44) |
| CBFβ/MYH11, n (%) | 37 (7) |
| CBFβ/MYH11/c-KITmut, n (%) | 4/37 (11) |
| FLT3-ITDmut, n (%) | 46 (9) |
| NPM1mut, n (%) | 107 (21) |
| NPM1mut/FLT3-ITDmut, n (%) | 80 (16) |
| NCCN-FR, n (%) | 138 (28) |
| NCCN-IR, n (%) | 127 (25) |
| NCCN-IR-no LAIP, n (%) | 47 (9) |
| NCCN-PR, n (%) | 188 (38) |
| . | Overall . |
|---|---|
| No. | 500 |
| Median age (range) | 49 (18-60,9) |
| Sex, n (%) | |
| Male | 260 (52) |
| Female | 240 (48) |
| Median WBCc (range) | 14 × 109/L (0.16-352) |
| Cytogenetics: FR, n (%) | 47 (11) |
| Cytogenetics: IR, n (%) | 315 (73) |
| Cytogenetics: PR, n (%) | 67 (16) |
| RUNX1/RUNX1T1, n (%) | 27 (5) |
| RUNX1/RUNX1T1/c-KITmut, n (%) | 12/27 (44) |
| CBFβ/MYH11, n (%) | 37 (7) |
| CBFβ/MYH11/c-KITmut, n (%) | 4/37 (11) |
| FLT3-ITDmut, n (%) | 46 (9) |
| NPM1mut, n (%) | 107 (21) |
| NPM1mut/FLT3-ITDmut, n (%) | 80 (16) |
| NCCN-FR, n (%) | 138 (28) |
| NCCN-IR, n (%) | 127 (25) |
| NCCN-IR-no LAIP, n (%) | 47 (9) |
| NCCN-PR, n (%) | 188 (38) |
WBCc, white blood cell count.